Cannabidiol, a non-psychoactive cannabinoid, leads to EGR2-dependent anergy in activated encephalitogenic T cells

BACKGROUND: Cannabidiol (CBD), the main non-psychoactive cannabinoid, has been previously shown by us to ameliorate clinical symptoms and to decrease inflammation in myelin oligodendrocyte glycoprotein (MOG)35-55-induced mouse experimental autoimmune encephalomyelitis model of multiple sclerosis as...

Descripción completa

Detalles Bibliográficos
Autores principales: Kozela, Ewa, Juknat, Ana, Kaushansky, Nathali, Ben-Nun, Avraham, Coppola, Giovanni, Vogel, Zvi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4363052/
https://www.ncbi.nlm.nih.gov/pubmed/25880134
http://dx.doi.org/10.1186/s12974-015-0273-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4363052/
https://www.ncbi.nlm.nih.gov/pubmed/25880134
http://dx.doi.org/10.1186/s12974-015-0273-0

Ejemplares similares